The Impact of Palivizumab for Respiratory Syncytial Virus Prophylaxis on Preschool Childhood Asthma
While Palivizumab effectively reduces RSV acute bronchiolitis in preterm infants, it does not significantly impact long-term preschool asthma-related healthcare utilization.
Authors
- Guy Hazan (ORCID: https://orcid.org/0000-0002-7372-6262)
- David A. Greenberg
- Inbal Golan‐Tripto (ORCID: https://orcid.org/0000-0001-6259-405X)
- Henry Hasson
- Yoav Bachar
- Aviv Goldbart (ORCID: https://orcid.org/0000-0002-7063-4653)
- Itai Hazan (ORCID: https://orcid.org/0000-0002-6064-6909)
Institutions
- Ben-Gurion University of the Negev (IL)
- Soroka Medical Center (IL)
Publication Details
- Journal
- Vaccines
- Published
- 2024-11-10
- DOI
- https://doi.org/10.3390/vaccines12111269
- Citations
- 7
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 2.71